Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Magenta Therapeutics Inc.

    NASDAQ: MGTA · Real-Time Price · USD
    0.70
    -0.06 (-7.69%)
    At close: Sep 11, 2023, 10:00 PM

    Magenta Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.24M n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -101.86M -80.9M -74.69M
    Interest Income
    		 17.36M n/a 3.56M
    Pretax Income
    		 -84.97M -76.46M -71.14M
    Net Income
    		 -84.97M -72.02M -65.56M
    Selling & General & Admin
    		 24.99M 25.76M 27.93M
    Research & Development
    		 83.11M 55.14M 46.77M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 108.1M 80.9M 74.69M
    Interest Expense
    		 n/a -4.44M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 n/a 80.9M 74.69M
    Income Tax Expense
    		 n/a -4.44M -5.58M
    Shares Outstanding (Basic)
    		 3.91M 3.12M 58.79M
    Shares Outstanding (Diluted)
    		 3.91M 3.12M 58.79M
    EPS (Basic)
    		 -21.75 -23.05 -1.12
    EPS (Diluted)
    		 -21.75 -23.05 -1.12
    EBITDA
    		 -101.86M -78.98M -74.69M
    EBIT
    		 n/a -80.9M n/a
    Depreciation & Amortization
    		 n/a 1.93M 2.02M

    Add to Watchlist